Literature DB >> 10930056

Hepatic damage caused by chronic arsenic toxicity in experimental animals.

A Santra1, A Maiti, S Das, S Lahiri, S K Charkaborty, D N Mazumder.   

Abstract

OBJECTIVE: Noncirrhotic fibrosis of the liver is common in subjects chronically consuming ground water geologically contaminated with arsenic, but the mechanism of the hepatic fibrosis is not known. Because lipid peroxidation has been implicated in the development of several other forms of hepatic fibrosis, including iron and copper overload, we have explored the roles of oxidative stress and lipid peroxidation in the causation of hepatic fibrosis in a murine model of chronic arsenic toxicity.
METHODS: Male BALB/c mice were given drinking water contaminated with arsenic (3.2 mg/L) or arsenic-free (<0.01 mg/L, control) ad libitum. Mice were sacrificed at 3, 6, 9, 12, and 15 months for examination of hepatic histology and assays of hepatic reduced glutathione content, lipid peroxidation, enzymes of the antioxidant defense system, and membrane-bound sodium/potassium ATPase (Na+/K+ ATPase).
RESULTS: After 12 months of arsenic feeding, the liver weights increased significantly as did serum aspartate aminotransferase and alanine aminotransferase. After 6 months of arsenic feeding, hepatic glutathione and the enzymes glucose-6-phosphate dehydrogenase and glutathione peroxidase were significantly lower than those of the control group. Hepatic catalase activity was significantly reduced at 9 months in the arsenic-fed group, while glutathione-S-transferase and glutathione reductase activities were also significantly reduced at 12 and 15 months. Plasma membrane Na+/K+ ATPase activity was reduced after 6 months while lipid peroxidation increased significantly after 6 months of arsenic feeding. Liver histology remained normal for the first 9 months, but showed fatty infiltration after 12 months of arsenic feeding. Histologic evidence of fibrosis was observed after 15 months.
CONCLUSION: We have demonstrated hepatic fibrosis due to long-term arsenic toxicity in an animal model. Initial biochemical evidence of hepatic membrane damage, probably due to reduction of glutathione and antioxidant enzymes, may be seen by 6 months. Continued arsenic feeding resulted in fatty liver with serum aminotransferase and alanine aminotransferase elevated at 12 months and hepatic fibrosis at 15 months. The murine model is proposed as relevant to epidemic human toxicity in areas of arsenic contamination.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930056     DOI: 10.1081/clt-100100949

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  43 in total

1.  Ameliorative Potential of Psidium guajava on Hemato-biochemical Alterations in Arsenic-exposed Wistar Rats.

Authors:  Neeraj Tandan; Manju Roy; Sushovan Roy
Journal:  Toxicol Int       Date:  2012-05

2.  Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice.

Authors:  Min Tan; Robin H Schmidt; Juliane I Beier; Walter H Watson; Hai Zhong; J Christopher States; Gavin E Arteel
Journal:  Toxicol Appl Pharmacol       Date:  2011-09-29       Impact factor: 4.219

3.  Oligofructose protects against arsenic-induced liver injury in a model of environment/obesity interaction.

Authors:  Veronica L Massey; Kendall S Stocke; Robin H Schmidt; Min Tan; Nadim Ajami; Rachel E Neal; Joseph F Petrosino; Shirish Barve; Gavin E Arteel
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-08       Impact factor: 4.219

4.  Arsenic responsive microRNAs in vivo and their potential involvement in arsenic-induced oxidative stress.

Authors:  Xuefeng Ren; Daniel P Gaile; Zhihong Gong; Wenting Qiu; Yichen Ge; Chuanwu Zhang; Chenping Huang; Hongtao Yan; James R Olson; Terrance J Kavanagh; Hongmei Wu
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-24       Impact factor: 4.219

5.  Biochemical investigation of association of arsenic exposure with risk factors of diabetes mellitus in Pakistani population and its validation in animal model.

Authors:  Kanwal Rehman; Fiza Fatima; Muhammad Sajid Hamid Akash
Journal:  Environ Monit Assess       Date:  2019-07-25       Impact factor: 2.513

6.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

7.  Adenine nucleotide-mediated regulation of hepatic PTP1B activity in mouse models of type 2 diabetes.

Authors:  Xiao Yang; Yang Zhao; Qi Sun; Yunxia Yang; Yan Gao; Wenhao Ge; Junhao Liu; Xi Xu; Dan Weng; Shiming Wang; Jianfa Zhang
Journal:  Diabetologia       Date:  2019-08-13       Impact factor: 10.122

8.  Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice.

Authors:  Subhadip Ghatak; Ayan Biswas; Gopal Krishna Dhali; Abhijit Chowdhury; James L Boyer; Amal Santra
Journal:  Toxicol Appl Pharmacol       Date:  2010-12-04       Impact factor: 4.219

Review 9.  Oxidative mechanism of arsenic toxicity and carcinogenesis.

Authors:  Honglian Shi; Xianglin Shi; Ke Jian Liu
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

10.  Subhepatotoxic exposure to arsenic enhances lipopolysaccharide-induced liver injury in mice.

Authors:  Gavin E Arteel; Luping Guo; Thomas Schlierf; Juliane I Beier; J Phillip Kaiser; Theresa S Chen; Marsha Liu; Daniel J Conklin; Heather L Miller; Claudia von Montfort; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-31       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.